Research Article
Association between Circulating B-Type Natriuretic Peptide and Diabetic Peripheral Neuropathy: A Cross-Sectional Study of a Chinese Type 2 Diabetic Population
Table 1
Circulating levels of BNP and other clinical characteristics between T2DM patients with and without DPN.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data are . SD: standard deviation; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; FBG: fasting blood glucose; HbA1c: glycated hemoglobin A1c; TC: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; NLR: neutrophil-to-lymphocyte ratio; WBC: white blood cell; RDW: red cell distribution width; PT: prothrombin time; APTT: activated partial thromboplastin time; INR: international normalized ratio; BNP: B-type natriuretic peptide; ACR: albumin-to-creatinine ratio; eGFR: estimated glomerular filtration rate; VPT: vibration perception threshold; ABI: ankle-brachial index; CHD: coronary heart disease; DFU: diabetic foot ulceration; PAD: peripheral arterial disease; DN: diabetic nephropathy; DR: diabetic retinopathy; DPN: diabetic peripheral neuropathy; T2DM: type 2 diabetes mellitus. |